Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Garmash (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), D. Ivanova (Moscow, Russian Federation). Long-term follow-up of patients with pulmonary sarcoidosis. 3010

Member's Comments

No comment yet.

Related content which might interest you: Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Long-term follow-up of children diagnosed with pulmonary hypoplasia Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Five years follow-up after pulmonary rehabilitation of patients with COPD Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010 Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 One year follow-up of patients with idiopathic pulmonary fibrosis treated with immunosuppressive therapy Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 Prognosis of pulmonary sarcoidosis in young patients Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003 Long-term outcome of pulmonary rehabilitation in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003 The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Clinical-radiological and functional follow-up of pulmonary sequelae after COVID-19 Source: Virtual Congress 2021 – Chronic COVID - 19 Year: 2021 Long-term benefits of pulmonary rehabilitation in patients with chronic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002 Long-term follow-up after endoscopic valve therapy in patients with severe emphysema Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects Year: 2011 Early pulmonary hemodynamical changes in systemic sclerosis. A one-year follow-up Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias Source: ERJ Open Res, 5 (2) 00045-2019; 10.1183/23120541.00045-2019 Year: 2019 Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 One-year observation of iloprost inhalation therapy in patients with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 324s Year: 2001 Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 Long-term effect of low-intensity home-based pulmonary rehabilitation in patients with COPD and non-COPD – a five-year follow-up Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients Year: 2007 Longer-term survival in paediatric patients with idiopathic or familial pulmonary arterial hypertension treated with bosentan Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009